Nitric oxide protection against adriamycin-induced tubulointerstitial injury

Free Radical Research

Volumn 42, Issue 2, 2008, Pages 154-161

  Oteki, Takaaki ^a   Nagase, Sohji ^a   Shimohata, Homare ^b   Hirayama, Aki ^b   Ueda, Atsushi ^c   Yokoyama, Hidekatsu ^d   Yoshimura, Tetsuhiko ^e  

^a INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Namegata District General Hospital   (Japan)

^d NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^e Yamagata Promotional Organization for Industrial Technology   (Japan)

Author keywords

Adriamycin induced sodium excretion; Electron paramagnetic resonance; In vivo spin trapping technique; N (3 (aminomethyl)benzyl)acetamidine (1400W); Nitric oxide

Indexed keywords

DOXORUBICIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; RAT; SODIUM EXCRETION; SPIN TRAPPING;

AMIDINES; ANIMALS; BENZYLAMINES; BETA-N-ACETYLHEXOSAMINIDASES; DEOXYGUANOSINE; DOXORUBICIN; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENZYME INHIBITORS; KIDNEY; MALE; NEPHRITIS, INTERSTITIAL; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RATS;

ANIMALIA;

EID: 39749180886     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760701840047     Document Type: Article

References (47)

1. Sato, S., Iwaizumi, M., Handa, K. and Tamura, Y. (1997) Electron spin resonance study on the mode of generation of free radicals of daunomycin, adriamycin, and carboquone in NAD(P)H-microsome system. Gann, 68, pp. 603-608.
2. Davis, KJ, Doroshow, JH and Hochstein, P. (1983) Mitochondrial NADH dehydrogenase-catalyzed oxygen radical production by Adriamycin, and the relative inactivity of 5-iminodaunorubicin. FEBS Lett, 153, pp. 227-230.
3. Mikkelsen, RB and Wardman, P. (2003) Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene, 22, pp. 5734-5754.
4. Pfeilschifter, J., Kunz, D. and Muhl, H. (1993) Nitric oxide: An inflammatory mediation of glomerular mesangial cells. Nephron, 64, pp. 518-525.
5. Moncada, S., Palmer, RMJ and Higgs, EA. (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev, 138, pp. 109-142.
6. Ignarro, LJ. (1996) Physiology and pathophysiology of nitric oxide. Kidney Int Suppl, 55, pp. S2-S5.
7. Woltz, M., Schmetterer, L., Ferber, W., Artner, E., Mensik, C., Eichler, HG and Krejcy, K. (1997) Effect of nitric oxide synthase inhibitor on renal hemodynamics in humans: Reversal by L-arginine. Am J Physiol, 272, pp. F178-F182.
8. Duquaine, D., Hirsch, GA, Chakrabarti, A., Han, Z., Kehrer, C., Brook, R., Joseph, J., Schott, A., Kalyanaraman, B., Vasquez-Vivar, J. and Rajagopalan, S. (2003) Rapid-onset endothelial dysfunction with adriamycin: Evidence for a dysfunctional nitric oxide synthase. Vasc Med, 8, pp. 101-107.
9. Vasquez-Vivar, J., Martasek, P., Hogg, N., Masters, BS, Pritchard Jr, KA and Kalyanaraman, B. (1997) Endotherial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry, 36, pp. 11293-11297.
10. Matsuda, H., Kimura, S. and Iyanagi, T. (2000) One-electron reduction of quinines by the neuronal nitric-oxide synthase reductase domain. Biochim Biophys Acta, 1459, pp. 106-116.
11. Inagaki, R., Taniguchi, T., Sakai, T., Hayashi, N., Ishii, Y. and Muramatsu, I. (1999) Anticancer drugs inhibit induction of NO synthase in rat in vivo. Gen Pharmacol, 32, pp. 185-188.
12. Jung, ID, Lee, JS, Yun, SY, Park, CG, Han, JW, Lee, HW and Lee, HY. (2002) Doxorubicin inhibits the production of nitric oxide by colorectal cancer cells. Arch Pharm Res, 25, pp. 691-696.
13. Ozen, S., Usta, Y., Sahin-Erdemli, I., Orhan, D., Gumusel, B., Yang, B., Gursoy, Y., Tulunay, O., Dalkara, T., Bakkaloglu, A. and EI-Nahas, M. (2001) Association of nitric oxide production and apoptosis in a model of experimental nephropathy. Nephrol Dial Transplant, 16, pp. 32-38.
14. Rangan, GK, Wang, Y. and Harris, DC. (2001) Pharmacologic modulation of nitric oxide exacerbate tubulointerstitial inflammation in proteinuric rats. J Am Soc Nephrol, 12, pp. 1696-1705.
15. Endoh, H., Kato, N., Fujii, S., Suzuki, Y., Sato, S., Kayama, T., Kotake, Y. and Yoshimura, T. (2001) Spin trapping agent, phenyl N-tert-butylnitrone, reduces nitric oxide production in the rat brain during experimental meningitis. Free Radic Res, 35, pp. 583-591.
16. Sugata, H., Ueno, T., Shimosegawa, T. and Yoshimura, T. (2003) Direct detection of nitric oxide and its roles in maintaining gastric mucosal integrity following ethanol-induced injury in rats. Free Radic Res, 37, pp. 159-169.
17. Uno, K., Iuch, Y., Fujii, J., Sugata, H., Iijima, K., Kato, K., Shimosegawa, T. and Yoshimura, T. (2004) In vivo study on cross talk between inducible nitric-oxide synthase and cyclooxygenase in rat gastric mucosa: Effect of cyclooxygenase. J Pharmacol Exp Ther, 309, pp. 995-1002.
18. Asanuma, K., Iijima, K., Sugata, H., Ohara, S., Shimosegawa, T. and Yoshimura, T. (2005) Diffusion of cytotoxic concentration of nitric oxide generated luminally at the gastro-oesophageal junction of rats. Gut, 54, pp. 1072-1077.
19. Kubrina, LN, Mikoyan, VD, Mordvintcev, PI and Vanin, AF. (1993) Iron potenciates bacterial lipopolysaccharide-induced nitric oxide formation in animal organs. Biochim Biophys Acta, 1176, pp. 240-244.
20. Wallis, G., Brackett, D., Lerner, M., Kotake, Y., Bolli, R. and McCay, PB. (1996) In vivo spin trapping of nitric oxide generated in the small intestine, liver, and kidney during the development of endotoxemia: A time course study. Shock, 6, pp. 274-278.
21. Nagano, T. and Yoshimura, T. (2002) Bioimaging of nitric oxide. Chem Rev, 102, pp. 1235-1270.
22. Garvey, EP, Oplinger, JA, Furfine, ES, Kiff, RJ, Laszlo, F., Whittle, BJ and Knowles, RG. (1997) 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem, 272, pp. 4959-4963.
23. Hamilton, LC and Warner, TD. (1998) Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenase in vivo: investigations using the selective inhibitors, 1400W and celecoxib. Br J Pharmacol, 125, pp. 335-340.
24. Jafarian-Tehrani, M., Louin, G., Royo, NC, Besson, VC, Bohme, GA, Plotkine, M. and Marchand-Verrecchia, C. (2005) 1400W, a potent selective inducible NOS inhibitor, improves histopathological outcome following traumatic brain injury in rats. Nitric Oxide, 12, pp. 61-69.
25. Henry, Y., Ducrocq, C., Drapier, JC, Servent, D., Pellat, C. and Guissani, A. (1991) Nitric oxide, a biological effector. Electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whole cells. Eur Biophys J, 20, pp. 1-15.
26. Henry, Y., Lepoivre, M., Drapier, JC, Ducrocq, C., Boucher, JL and Guissani, A. (1993) EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J, 7, pp. 1124-1134.
27. Yoshimura, T. and Kotake, Y. (2004) Spin trapping of nitric oxide with the iron-dithiocarbamate complex: Chemistry and biology. Antioxid Redox Signal, 6, pp. 639-647.
28. Berliner, LJ, Khramtsov, V., Fujii, H. and Clantor, TL. (2001) Unique in vivo applications of spin traps. Free Radic Biol Med, 30, pp. 489-499.
29. Vanin, AF. (1999) Iron diethyldithiocarbamate as spin traps for nitric oxide detection. Methods Enzymol, 301, pp. 269-279.
30. Ohnishi, ST. (1998) Measurement of NO using electron paramagnetic resonance. Methods Mol Biol, 100, pp. 129-153.
31. Laszlo, F., Evans, SM and Whittle, BJ. (1995) Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur J Pharmacol, 272, pp. 169-175.
32. Hasan, K., Heesen, BJ, Corbett, JA, McDaniel, ML, Chang, K., Allison, W., Wolffenbuttel, BH, Williamson, JR and Tilton, RG. (1993) Inhibition of nitric oxide formation by guanidine. Eur J Pharmacol, 249, pp. 101-106.
33. Corbett, JA, Tilton, RG, Chang, K., Hasan, KS, Ido, Y., Wang, JL, Sweetland, MA, Lancaster Jr, JR, Williamson, JR and McDaniel, ML. (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes, 41, pp. 552-556.
34. Chaisuing, L., Cole, MP, Ittarat, W., Szweda, LI, Chair, DK St. and Oberley, TD. (2005) Manganese superoxide dismutase and inducible nitric oxide synthase modify early oxidative events in acute adriamycin-induced mitochondrial toxicity. Mol Cancer Ther, 4, pp. 1056-1064.
35. Jo, SK, Hu, X., Yuen, PS, Aslamkhan, AG, Pritchard, JB, Dear, JW and Star, RA. (2004) Delayed DMSO administration protects the kidney from mercuric chloride-induced injury. J Am Soc Nephrol, 15, pp. 2648-2654.
36. Oteki, T., Nagase, S., Yokoyama, H., Ohya, H., Akatsuka, T., Tada, M., Ueda, A., Hirayama, A. and Koyama, A. (2005) Evaluation of adriamycin nephropathy by an in vivo electron paramagnetic resonance. Biochem Biophys Res Comm, 332, pp. 326-331.
37. Oteki, T., Nagase, S., Yokoyama, H., Ohya, H., Akatsuka, T., Tada, M., Ueda, A., Hirayama, A. and Koyama, A. (2005) Normalizing renal reducing ability prevents adriamycin-induced proteinuria. Biochem Biophys Res Comm, 337, pp. 48-51.
38. Ji, Z., Huang, C., Liang, C., Chen, B., Chen, S. and Sun, W. (2005) Protective effects of blocking rennin-angiotensin system on the progression of renal injury in glomerulosclerosis. Cell Mol Immunol, 2, pp. 150-154.
39. Kone, BC and Baylis, C. (1997) Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol, 272, pp. F561-F578.
40. Manning Jr, RD and Hu, L. (1994) Nitric oxide regulates renal hemodynamics and urinary sodium excretion in dogs. Hypertension, 23, pp. 619-625.
41. Stoos, BA and Garvin, JL. (1997) Actions of nitric oxide on renal epithelial transport. Clin Exp Pharmacol Physiol, 24, pp. 591-594.
42. Majid, DS and Navar, LG. (2001) Nitric oxide in the control of renal hemodynamics and excretory function. Am J Hypertension, 14, pp. 74S-82S.
43. +-ATPase alpha1-subunit gene in an MTAL cell line. Am J Physiol, 276, pp. F614-F621.
44. Kumar, U., Chen, J., Sapoznikhov, V., Canteros, G., White, BH and Sidhu, A. (2005) Overexpression of inducible nitric oxide synthase in the kidney of the spontaneously hypertensive rat. Clin Exp Hypertens, 27, pp. 17-31.
45. Fujiwara, K., Shin, M., Hougaard, DM and Larsson, LI. (2006) Distribution of anticancer antibiotic daunomycin in the rat heart and kidney revealed by immunocytochemistry using monoclonal antibodies. Histochem Cell Biol, 127, pp. 69-77.
46. Morin, MJ, Unno, N., Hodin, RA and Fink, MP. (1998) Differential expression of inducible nitric oxide synthase messenger RNA along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats. Crit Care Med, 26, pp. 1258-1264.
47. Gookin, JL, Rhoads, JM and Argenzio, RA. (2002) Inducible nitric oxide synthase mediates early epithelial repair of porcine ileum. Am J Physiol Gastrointest Liver Physiol, 283, pp. G157-G168.